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Abstract
Background: The a-adducin Gly460Trp (G460W) gene polymorphism may be associated with susceptibility to essential
hypertension (EH), but this relationship remains controversial. In an attempt to resolve this issue, we conducted a meta-
analysis.
Methods: Twenty-three separated studies involving 5939 EH patients and 5021 controls were retrieved and analyzed. Four
ethnicities were included: Han, Kazakh, Mongolian, and She. Eighteen studies with 5087 EH patients and 4183 controls were
included in the Han subgroup. Three studies with 636 EH patients and 462 controls were included in the Kazakh subgroup.
The Mongolian subgroup was represented by only one study with 100 EH patients and 50 controls; similarly, only one study
with 116 EH patients and 326 controls was available for the She subgroup. The pooled and ethnic group odds ratios (ORs)
along with the corresponding 95% confidence intervals (95% CI) were assessed using a random effects model.
Results: There was a significant association between the a-adducin G460W gene polymorphism and EH in the pooled
Chinese population under both an allelic genetic model (OR: 1.12, 95% CI: 1.04–1.20, P=0.002) and a recessive genetic
model (OR: 1.40, 95% CI: 1.16–1.70, P=0.0005). In contrast, no significant association between the a-adducin G460W gene
polymorphism and EH was observed in the dominant genetic model (OR: 0.88, 95% CI: 0.72–1.09, P=0.24). In stratified
analysis by ethnicity, significantly increased risk was detected in the Han subgroup under an allelic genetic model (OR: 1.13,
95% CI: 1.04–1.23, P=0.003) and a recessive genetic model (OR: 1.43, 95% CI: 1.17–1.75, P=0.0006).
Conclusions: In a Chinese population of mixed ethnicity, the a-adducin G460W gene polymorphism was linked to EH
susceptibility, most strongly in Han Chinese.
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Introduction
Essential hypertension (EH) is one of the primary causes of
cardiovascular diseases. It is a polygenic hereditary disease with a
complex pathogenesis that is strongly influenced by environmental
and lifestyle factors. Previous studies have indicated that abnormal
renal membrane ion transport might play a key role in the onset of
EH [1]. There is now a general consensus that the increase in
circulating blood volume due to increased renal sodium reabsorp-
tion is a major pathogenic factor leading to EH. Adducin is a
cytoskeleton protein composed of two subunits (one a-subunit and
either a b-o rc-subunit). Adducin has been implicated in the
construction and maintenance of the cytolemma framework. In
addition, adducin regulates cellular signal transduction and
cytolemma ion transport by modulating the surface expression of
multiple transporters and pumps, including the Na
+-H
+ exchang-
er, Na
+-K
+-Cl
2 cotransporter, and the sodium pump [2].
Regulation of renal Na
+ transport by the adducin protein suggests
that allelic variants of adducin may contribute to EH.
The human a-adducin gene, located on 4p16.3, is composed of 16
exons. In 1997, Cusi et al first reported a missense point mutation
substituting thymine (T) for guanine (G) at position 614 of the 10
th
exon, resulting in an expressed adducin a subunit with Trp (W) in
place of the wild type Gly (G) at amino acid 460. In 2004, Beeks et al
found that this a-adducin 460W mutant markedly influenced renal
haemodynamics and function. The evident drop in effective renal
blood flow and glomerular filtration rate (GFR) in the WW genotype
led to excess water and sodium retention, even when patients main-
tained a low salt diet [3]. It was suggested that the (GRW) alteration
of a-subunit might affect protein assembly or stability, leading to
changes in submembrane cytoskeleton structure, increased sodium
reabsorption by the proximal renal tubules, and reduced GFR.
Enhanced water and sodium retention could increase circulating
blood flow volume and cause high BP. It remains to be established,
however, if the a-adducin G460W gene polymorphism does indeed
increase susceptibility to a salt-sensitive form of hypertension [4].
In China, hypertensive patients have three features: salt-
sensitivity, great BP fluctuation, and high stroke morbidity.
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7 1Approximately 60% of Chinese hypertensives are salt-sensitive
(meaning BP would be elevated by a high salt diet). Recent studies
have linked a-adducin to salt-sensitive hypertension but have not
investigated the specific polymorphisms. Confirmation of the a-
adducin G460W gene polymorphism as a mediator of salt-sensitive
hypertension would define a high value target for hypertension
therapy.
These association results are still controversial. An association
between a-adducin G460W and EH has been demonstrated in
Scandinavians and Japanese cohort [5–6], but no association was
found in African-Americans, Australians of Britain ancestry, or
Indians [7–9]. Liu et al (2010) performed a meta-analysis and
failed to detect a genetic association between the a-adducin gene
G460W polymorphism and hypertension in Caucasians, East
Asians, South Africans, and African-Americans [10]. Furthermore,
results from various population samples in China were also
inconsistent. In 2011, Niu et al reported a null association between
the a-adducin G460W gene polymorphism and hypertension in
Chinese population in another meta-analysis [11]. In contrast, a
meta-analysis of 20 stuides by Liu et al in 2011 suggested that the
G460W polymorphism might increase the risk of hypertension in
Chinese populations, especially in Han Chinese [12]. However,
there were still some limitations in their work. For instance, the
subgroup analysis by salt intake area was not performed. The
literatures have not been retrieved completely. Two studies
deviating from the Hardy-Weinberg equilibrium (HWE) were still
included in that mata-analysis which inevitably influenced the
results [13–14].
In consideration of these conflicting results and the above
limitations, it is unclear yet whether there is a significant
association between the a-adducin G460W gene polymorphism
and EH in Chinese population. The current meta-analysis
Figure 1. Flow diagram of articles selection process for a-adducin G460W gene polymorphism and EH risk meta-analysis.
doi:10.1371/journal.pone.0030214.g001
a-Adducin Gly460Trp Gene Mautation and EH
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controls was important to be performed to derive a more precise
estimate of the association between a-adducin G460W gene
polymorphism and EH in individual ethnicities within China.
Compared with Liu’s work, there were some similarities. For
example, two statistical models as recessive and dominant genetic
models were adopted in both meta-analysises. There were 18
individual studies overlapped between them. Because of the
limitations in Liu’s work, subgroup analysis stratified by salt
intake was additionally conducted in the Chinese Han popula-
tion. Moreover, the retrieved individual studies were more
comprehensive and exact than those in Liu’s work. So the
present meta-analysis has potential to add to the current
knowledge.
Materials and Methods
Publication search and inclusion criteria
The electronic databases PubMed, Embase, Web of Science,
China Biological Medicine Database (CBMD), and China
National Knowledge Infrastructure (CNKI) were searched for
studies using the MeSH terms ‘hypertension’, ‘a-adducin’, ‘poly-
morphism’, ‘hypertension’, ‘gene’, and Chinese’. The compiled
data set was last updated on May 4, 2011, and included published
papers from 1999 to 2011.
The reports included had to meet the following criteria: (a)
evaluation of the a-adducin G460W gene polymorphism and EH in
a Chinese population, and (b) diagnosis of EH in agreement with
the EH diagnosis criteria of the World Health Organization
Figure 2. Forest plot of essential hypertension associated with a-adducin Gly460Trp gene polymorphism under an allelic genetic
model (distribution of Trp allelic frequency of a-adducin gene) stratified by ethnicity.
doi:10.1371/journal.pone.0030214.g002
a-Adducin Gly460Trp Gene Mautation and EH
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diastolic BP$90 mmHg, or treatment with antihypertensive
medication defines EH.
Data extraction
No paper was included if it did not meet the two aforemen-
tioned inclusion criteria. When the same study results appeared in
several papers, only one study was used in this meta-analysis. The
extracted data included the first author’s name, publication date,
region of study, ethnicity of the sample population, number of
genotypes, and the total number of cases and controls (Supplement
S1). Different ethnicities in China were categorized as Han,
Kazakh, Mongolian, or She. The study regions included the three
directly governed city regions Beijing, Shanghai, and Tianjin, the
seven provinces Jiangsu, Fujian, Heilongjiang, Henan, Hebei,
Shanxi, and Zhejiang, and the two autonomous regions Xinjiang,
Neimenggu. These data were independently gathered using a
standard retrieval protocol.
Statistical analysis
Three statistical models as allelic genetic models (distribution of
Trp allelic frequency of a-adducin gene), recessive genetic models
(TrpTrp vs.GlyGly+GlyTrp) and dominant genetic models
(GlyGly vs. GlyTrp+ TrpTrp) were used in the current meta-
Figure 3. Forest plot of essential hypertension associated with a-adducin Gly460Trp gene polymorphism under a recessive genetic
model (TrpTrp vs.GlyGly+GlyTrp) stratified by ethnicity.
doi:10.1371/journal.pone.0030214.g003
a-Adducin Gly460Trp Gene Mautation and EH
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interval (CI) was used to examine the association between the a-
adducin G460W gene polymorphism and EH. The heterogeneity
assumption was checked by the Chi-square-based Q-test and
significance was set at P,0.05 [15]. The variation caused by the
heterogeneity was also evaluated by calculating the inconsistency
index I
2 where a higher value of I
2 indicates heterogeneity. A
random-effects model was used for all analyses (the DerSimonian
and Laird method) [16–17]. HWE was assessed by Fisher’s exact
test and P,0.05 indicated a significant deviation for HWE. Funnel
plots were used to estimate the potential publication bias. The
funnel plot asymmetry on the natural logarithm scale of the OR
was assessed by Egger’s linear regression test and significance was
also set at P,0.05 [18]. Subgroup analysis stratified by salt intake
was performed to observe the effect of dietary salt on the
association of a-adducin G460W gene polymorphism and EH.
Meta-regression was performed to explore the sources of
heterogeneity. Significance was set at P,0.05. The statistical
analysis was performed using STATA 10.0 software (StataCorp,
College Station, TX).
Results
Studies and populations
Forty papers were retrieved by literature search, of which 23
conformed to the study inclusion criteria. Of the 17 excluded
Figure 4. Forest plot of essential hypertension associated with a-adducin Gly460Trp gene polymorphism under a dominant genetic
model (GlyGly vs. GlyTrp+ TrpTrp) stratified by ethnicity.
doi:10.1371/journal.pone.0030214.g004
a-Adducin Gly460Trp Gene Mautation and EH
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reviews, 2 deviated from HWE, and the remaining 8 did
not focus on the G460W gene polymorphism (Figure 1). The
total data of the 23 studies comprised 5939 EH patients
and 5021 controls from 12 districts and 4 ethnicities, Han,
Kazakh, Mongolian and She (Supplement S1) [19–41].
Eighteen studies with 5087 EH patients and 4183 controls
were included in the Han subgroup. Three studies with 636 EH
patients and 462 controls were included in the Kazakh
subgroup. Only one study each focused on Mongolian and
She populations, with 100 EH patients and 50 controls in the
Mongolian subgroup and 116 EH patients and 326 controls in
the She subgroup.
Pooled analyses
In the total Chinese population, there was a significant
association between the a-adducin G460W gene polymorphism
and EH under an allelic genetic model (OR: 1.12, 95% CI: 1.04–
1.20, P=0.002) and a recessive genetic model (OR: 1.40, 95% CI:
1.16–1.70, P=0.0005). No significant association between the a-
adducin Gly460Trp gene polymorphism and EH was observed in
the dominant genetic model (OR: 0.88, 95% CI: 0.72–1.09,
P=0.24). In the stratified analysis, significantly increased risk was
detected in the Han subgroup under an allelic genetic model (OR:
1.13, 95% CI: 1.04–1.23, P=0.003) and a recessive genetic model
(OR: 1.43, 95% CI: 1.17–1.75, P=0.0006). (Supplement S2,
Figures 2, 3 and 4)
The association between a-adducin G460W gene polymorphism
and EH risk was significant in the Mongolian Chinese population
under either the allelic genetic model (OR: 1.72, 95% CI: 1.06–
2.80, P=0.03) or recessive genetic model (OR: 7.32, 95% CI:
2.82–18.97, P,0.0001). There was no association evident in the
Kazakh subgroup under an allelic genetic model (OR: 1.02, 95%
CI: 0.86–1.21, P=0.81) or a recessive genetic model (OR: 1.08,
95% CI: 0.80–1.47, P=0.61). No significant association was found
in the She subgroup under an allelic genetic model (OR: 0.99,
95% CI: 0.73–1.34, P=0.95) or a recessive genetic model (OR:
0.90, 95% CI: 0.53–1.53, P=0.71) (Supplement S2, Figures 2 and
3).
Under a dominant genetic model, no significant increased risk
was found in the Han subgroup (OR: 0.86, 95% CI: 0.67–1.10,
P=0.24), Kazakh subgroup (OR: 1.04, 95% CI: 0.71–1.52,
P=0.86), Mongolian subgroup (OR: 0.72, 95% CI: 0.31–1.69,
P=0.45) or She subgroup (OR: 0.94, 95% CI: 0.55–1.61,
P=0.82) (Supplement S2, Figure 4)
The relationship between the a-adducin G460W gene polymor-
phism and EH might be strongly affected by salt intake. Mean
salt intake level was quite different between local areas and ethnic
groups in China. Accordingly, subgroup analysis was stratified
into a high salt intake area and low salt intake area according to
Figure 5. Forest plot of essential hypertension associated with a-adducin Gly460Trp gene polymorphism under an allelic genetic
model (distribution of Trp allelic frequency of a-adducin gene) stratified by salt intake area in Chinese Han population.
doi:10.1371/journal.pone.0030214.g005
a-Adducin Gly460Trp Gene Mautation and EH
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referred to as the low salt intake area and northern China was
considered the high salt intake area [42]. The two areas were
divided by the Yangtze River. In the high salt intake area, there
was a significant association under an allelic genetic model (OR:
1.19, 95% CI: 1.08–1.32, P=0.0005) , a recessive genetic model
(OR: 1.60, 95% CI: 1.18–2.17, P=0.003) and a dominant
genetic model (OR: 0.81, 95% CI: 0.66–0.99, P=0.04). By
contrast, no significant association between a-adducin G460W
gene polymorphism and EH was found in the low salt intake area
under an allelic genetic model (OR: 1.07, 95% CI: 0.95–1.22,
P=0.27), a recessive genetic model (OR: 1.25, 95% CI: 0.95–
1.62, P=0.08) or a dominant genetic model (OR: 0.94, 95% CI:
0.59–1.52, P=0.81). (Supplement S2, Figures 5, 6 and 7)
Meta-regression was conducted to explore the potential sources
of heterogeneity in the Han subgroup populations under an allelic
genetic model of inheritance by using STATA 10.0 software. The
study region, EH group sample size, control group sample size,
total sample size, ratio of EH group sample size to control group
sample size (RR), genotyping method were considered as the
potential confounding factors. Among these factors, RR, geno-
typing method, total sample size and control group sample size
might be possible explanations for the heterogeneity (P=0.014,
0.032, 0.042, 0.046) (P,0.05), while EH group sample size was not
associated (P.0.05) (Supplement S3 and S4).
In the subgroup analysis stratified by RR under an allelic and a
recessive model, subgroup 1 comprised studies with RR.1.20,
while subgroup 2 included studies with 1.0,RR#1.20. The
residual studies with RR#1.0 were classified as subgroup 3. In
subgroup 1, no significant association was observed between a-
adducin G460W gene polymorphism and EH under an allelic
genetic model (OR: 1.06, 95% CI: 0.92–1.23, Pheterogeneity=0.08,
I
2=48.7%, P=0.41) or under a recessive genetic model (OR:
1.16, 95% CI: 0.86–1.57, Pheterogeneity=0.02, I
2=63.3%,
P=0.33). Similarly in subgroup 2, there was no significant
association between a-adducin G460W gene polymorphism and
EH under an allelic genetic model (OR: 1.11, 95% CI: 0.96–1.30,
Pheterogeneity=0.15, I
2=37.7%, P=0.17) or under a recessive
genetic model (OR: 1.53, 95% CI: 0.97–2.43, Pheterogene-
ity=0.0002, I
2=79.5%, P=0.07). However, in subgroup 3, a
significant association was observed between a-adducin G460W
gene polymorphism and EH under an allelic genetic model (OR:
1.23, 95% CI: 1.06–1.42, Pheterogeneity=0.07, I
2=50.4%,
P=0.007) and under a recessive genetic model (OR: 1.61, 95%
CI: 1.17–2.22, Pheterogeneity=0.008, I
2=67.9%, P=0.004). (Sup-
plement S2, Figures 8, 9).
Bias diagnostics
The funnel plot and Egger’s test were used to assess the
publication bias of the literature for the allelic genetic model. No
Figure 6. Forest plot of essential hypertension associated with a-adducin Gly460Trp gene polymorphism under a recessive genetic
model (TrpTrp vs. GlyGly+GlyTrp) stratified by salt intake area in Chinese Han population.
doi:10.1371/journal.pone.0030214.g006
a-Adducin Gly460Trp Gene Mautation and EH
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(Figure 10). No significant difference was found in the Egger’s test
(T=0.65, P=0.523), which suggested that publication bias did not
exist in the current meta-analysis.
Discussion
In the current meta-analysis of 5,939 EH and 5,021 control
Chinese subjects, the a-adducin G460W gene polymorphism was
significantly associated with EH susceptibility under both the
allelic (OR: 1.12) and recessive genetic model (OR: 1.40), while
no association was found using a dominant genetic model (OR:
0.88). However, in the subgroup analysis by salt intake area, a
significant association was found under the allelic (OR: 1.19),
recessive genetic model (OR: 1.60) and dominant genetic model
(OR: 0.81) in the high salt intake area subgroup of Chinese Han
population.
In China, EH increases gradually after 30 years of age and is as
high as 18.8% in the total Chinese population. Among the EH
patients, about 60% are classified as salt-sensitive. Salt-sensitive
hypertension is controlled by genetics, but exacerbated by dietary
habits. The ratio of salt-sensitive hypertensive to normotensives
ranges from 15% to 42%, while the ratio of salt-sensitive
hypertensives to all hypertensives ranges from 28% to 74% in
different regions of China. Indeed, it is 28.57% in southern China
and 58% in northern China [31,43]. Moreover, the salt-
sensitivity increases with the age, especially in hypertensive
patients [44].
Allelic variance of the a-adducin gene could influence Na, K-
ATPase activity, thereby regulating water and sodium metabolism
and affecting BP [45–46]. In 2009, Stenstro ¨m reported that
blocking the salt-inducible kinase 1 network prevented the increase
in cell sodium transport caused by G460W, a hypertension-linked
mutation in human a-adducin [47]. Hence, a-adducin is clearly a
critical target for hypertension treatment in China. Not unexpect-
edly, the question of whether there is an association between the a-
adducin G460W gene polymorphism and EH in Chinese adults has
received a great deal of attention.
Differences in life styles might influence the role of the gene.
For instance, the genetic effects were clearly different between the
different salt intake areas [46]. The a-adducin protein plays a key
role in the regulation of the water and salt metabolism. There was
a significant difference in the salt intake level between the
southern and northern Han Chinese population [42]. In the
subsequent subgroup analysis by salt intake level, a significant
association was found between the a-adducin G460W gene
polymorphism and EH in the high salt intake area under the
three genetic models, while no significant association was
detected in the low salt intake area under the three genetic
models. This result suggested that salt intake level actually had an
Figure 7. Forest plot of essential hypertension associated with a-adducin Gly460Trp gene polymorphism under a dominant genetic
model (GlyGly vs. GlyTrp+ TrpTrp) stratified by salt intake area in Chinese Han population.
doi:10.1371/journal.pone.0030214.g007
a-Adducin Gly460Trp Gene Mautation and EH
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polymorphism and EH. Additionally, the higher OR in
Mongolians might also reflect specific life-style factors like high
salt intake (OR: 1.72 vs. 1.13, allelic genetic model; OR: 7.32
vs.1.43, recessive genetic model; OR: 0.72 vs. 0.86, dominant
genetic model) [47].
In the meta-regression, the candidate confounding factors RR
and genotyping methods were considered possible sources of
heterogeneity. Indeed, the RR could partly explain the
heterogeneity, indicating that the non-uniformity in the RR
contributed to the between-study heterogeneity. The effect of
genetics was greater in studies with RR#1.0 than in other studies
with RR.1.0, which suggested that the EH size and control size
should be better balanced. After adjusting for RR, unexplained
heterogeneity still existed. The association of the a-adducin
G460W gene polymorphism and EH was distinctly weakened
but still just significant in subsection 3 with RR#1.0. Therefore,
further studies should match the sizes of the cases and control
populations.
The present meta-analysis results were generally consistent with
the previous study by Liu [11], but there were several differences.
The stratified subgroup analysis by salt intake level was only
performed in the current study. Second, the She subgroup was not
included in their work [41] and four studies of the Han population
were excluded [19,22,34,36]. Two studies by Jing et al. and Huang
et al. that deviated from HWE were not excluded from Liu’s
research and excluded in the current meta-analysis [13–14].
Moreover, the heterogeneity source detection and corresponding
subgroup analysis were not performed. Hence, the conclusions
reached in the current meta-analysis provided stronger evidence
for a relationship between a-adducin Gly460Trp gene polymor-
phism and EH in China.
In summary, the current meta-analysis suggested that the
Gly460Trp allele of the a-adducin gene contributed to the
susceptibility of EH in Chinese populations, especially in Han
and Mongolia Chinese. Given that only one study has examined
this relationship in Mongolian and She populations, additional
studies should be launched to verify and extend these findings.
Figure 8. Forest plot of essential hypertension associated with a-adducin Gly460Trp gene polymorphism under an allelic genetic
model (distribution of Trp allelic frequency of a-adducin gene) stratified by RR in Chinese Han population. RR: the ratio of case size to
control size.
doi:10.1371/journal.pone.0030214.g008
a-Adducin Gly460Trp Gene Mautation and EH
PLoS ONE | www.plosone.org 9 January 2012 | Volume 1 | Issue 7 | e30214Figure 9. Forest plot of essential hypertension associated with a-adducin Gly460Trp gene polymorphism under a recessive genetic
model (TrpTrp vs.GlyGly+GlyTrp) stratified by RR in Chinese Han population. RR: the ratio of case size to control size.
doi:10.1371/journal.pone.0030214.g009
Figure 10. Funnel plot for studies of the association of essential hypertension and a-adducin Gly460Trp gene polymorphism under
an allelic genetic model (distribution of Trp allelic frequency of a-adducin gene). The horizontal and vertical axis correspond to the OR and
confidence limits. OR: odds ratio; SE: standard error.
doi:10.1371/journal.pone.0030214.g010
a-Adducin Gly460Trp Gene Mautation and EH
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